
Sunshine Biopharma Inc
NASDAQ:SBFM

Intrinsic Value
The intrinsic value of one
SBFM
stock under the Base Case scenario is
130.13
USD.
Compared to the current market price of 1.43 USD,
Sunshine Biopharma Inc
is
Undervalued by 99%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Fundamental Analysis


Revenue & Expenses Breakdown
Sunshine Biopharma Inc
Balance Sheet Decomposition
Sunshine Biopharma Inc
Current Assets | 24.5m |
Cash & Short-Term Investments | 8.1m |
Receivables | 3.4m |
Other Current Assets | 12.9m |
Non-Current Assets | 4.7m |
PP&E | 1.4m |
Intangibles | 3.2m |
Other Non-Current Assets | 92.2k |
Free Cash Flow Analysis
Sunshine Biopharma Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Sunshine Biopharma Inc
Revenue
|
36.2m
USD
|
Cost of Revenue
|
-25.2m
USD
|
Gross Profit
|
11m
USD
|
Operating Expenses
|
-16.8m
USD
|
Operating Income
|
-5.7m
USD
|
Other Expenses
|
678k
USD
|
Net Income
|
-5m
USD
|
SBFM Profitability Score
Profitability Due Diligence
Sunshine Biopharma Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Score
Sunshine Biopharma Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
SBFM Solvency Score
Solvency Due Diligence
Sunshine Biopharma Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Score
Sunshine Biopharma Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SBFM Price Targets Summary
Sunshine Biopharma Inc
Dividends
Current shareholder yield for SBFM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?